Stocks · Health care · Pharmaceutical Preparations

CYTOKINETICS INC

CYTK Clue Score32

United States Fiscal year ends December CIK 0001061983 Results filed 4 Nov 2026

Add to watchlist

What the insiders did Scheduled selling only

By person

16 insiders · 5 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Robert I Blum

President & CEO

—

$942.68K (2) scheduled

−$942.68K

286,876

0.2064%

$18.05M

−29.4%

Fady Ibraham Malik

EVP Research & Development

—

$659.12K (3) scheduled

−$659.12K

153,902

0.1107%

$9.69M

+33.3%

Jeffrey Hessekiel

Chief Legal & Admin Officer

—

—

—

107,943

0.0776%

$6.79M

—

John T Henderson

Director

—

—

—

78,795

0.0567%

$4.96M

+104.4%

Sung Lee

EVP, Chief Financial Officer

—

—

—

63,221

0.0455%

$3.98M

+82.3%

Andrew Callos

EVP, Chief Commercial Officer

—

—

—

58,555

0.0421%

$3.68M

−8.3%

Wendell Wierenga

Director

—

—

—

35,660

0.0257%

$2.24M

+10.2%

Nancy Wysenski

Director

—

—

—

34,089

0.0245%

$2.15M

+48.3%

Wendall Wierenga

Director

—

—

—

32,345

0.0233%

$2.04M

+31.7%

Muna Bhanji

Director

—

—

—

26,361

0.0190%

$1.66M

+49.5%

Robert Arthur Harrington

Director

—

—

—

22,127

0.0159%

$1.39M

+40.5%

Robert Wong

VP, Chief Accounting Officer

—

—

—

18,655

0.0134%

$1.17M

+7.2%

B Lynne Parshall

Director

—

—

—

10,784

0.0078%

$678.64K

−47.7%

Edward M. MD Kaye

Director

—

—

—

10,629

0.0076%

$668.88K

−58.1%

Robert E Landry

Director

—

—

—

8,184

0.0059%

$515.02K

—

James M Daly

Director

—

—

—

3,585

0.0026%

$225.60K

—